Photobiomodulation shows promise as safe and tolerable adjunct therapy for Parkinson’s Disease, recent trial suggests Post author: Post published: December 5, 2023 Post category:uncategorized A safe and feasible treatment option for reducing the motor signs of Parkinson’s disease. You Might Also Like Positive aging expectations linked to better cognitive perception October 29, 2024 Virtual voice technology enhances follow-up care for TAVI patients August 27, 2024 Drug combination could hold new promise for treating colorectal cancers and other solid tumors March 27, 2024
Drug combination could hold new promise for treating colorectal cancers and other solid tumors March 27, 2024